BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 16684959)

  • 1. Optimization of conditioning for marrow transplantation from unrelated donors for patients with aplastic anemia after failure of immunosuppressive therapy.
    Deeg HJ; O'Donnell M; Tolar J; Agarwal R; Harris RE; Feig SA; Territo MC; Collins RH; McSweeney PA; Copelan EA; Khan SP; Woolfrey A; Storer B
    Blood; 2006 Sep; 108(5):1485-91. PubMed ID: 16684959
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Marrow transplants from unrelated donors for patients with aplastic anemia: minimum effective dose of total body irradiation.
    Deeg HJ; Amylon ID; Harris RE; Collins R; Beatty PG; Feig S; Ramsay N; Territo M; Khan SP; Pamphilon D; Leis JF; Burdach S; Anasetti C; Hackman R; Storer B; Mueller B
    Biol Blood Marrow Transplant; 2001; 7(4):208-15. PubMed ID: 11349807
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cyclophosphamide conditioning in patients with severe aplastic anaemia given unrelated marrow transplantation: a phase 1-2 dose de-escalation study.
    Anderlini P; Wu J; Gersten I; Ewell M; Tolar J; Antin JH; Adams R; Arai S; Eames G; Horwitz ME; McCarty J; Nakamura R; Pulsipher MA; Rowley S; Leifer E; Carter SL; DiFronzo NL; Horowitz MM; Confer D; Deeg HJ; Eapen M
    Lancet Haematol; 2015 Sep; 2(9):e367-75. PubMed ID: 26685770
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bone marrow transplantation for severe aplastic anemia from genotypically HLA-nonidentical relatives. An update of the Seattle experience.
    Wagner JL; Deeg HJ; Seidel K; Anasetti C; Doney K; Sanders J; Sullivan KM; Storb R
    Transplantation; 1996 Jan; 61(1):54-61. PubMed ID: 8560574
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Beneficial Role of Low-Dose Antithymocyte Globulin in Unrelated Stem Cell Transplantation for Adult Patients with Acquired Severe Aplastic Anemia: Reduction of Graft-versus-Host Disease and Improvement of Graft-versus-Host Disease-Free, Failure-Free Survival Rate.
    Park SS; Kwak DH; Jeon YW; Yoon JH; Lee SE; Cho BS; Eom KS; Kim YJ; Kim HJ; Lee S; Min CK; Cho SG; Kim DW; Min WS; Lee JW
    Biol Blood Marrow Transplant; 2017 Sep; 23(9):1498-1508. PubMed ID: 28554856
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Choice of conditioning regimens for bone marrow transplantation in severe aplastic anemia.
    Bejanyan N; Kim S; Hebert KM; Kekre N; Abdel-Azim H; Ahmed I; Aljurf M; Badawy SM; Beitinjaneh A; Boelens JJ; Diaz MA; Dvorak CC; Gadalla S; Gajewski J; Gale RP; Ganguly S; Gennery AR; George B; Gergis U; Gómez-Almaguer D; Vicent MG; Hashem H; Kamble RT; Kasow KA; Lazarus HM; Mathews V; Orchard PJ; Pulsipher M; Ringden O; Schultz K; Teira P; Woolfrey AE; Saldaña BD; Savani B; Winiarski J; Yared J; Weisdorf DJ; Antin JH; Eapen M
    Blood Adv; 2019 Oct; 3(20):3123-3131. PubMed ID: 31648332
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Allogeneic stem cell transplantation from related and unrelated donors for aplastic anaemia in adults--a single-centre experience.
    Buchholz S; Dammann E; Koenecke Ch; Stadler M; Franzke A; Blasczyk R; Bremer M; Krauter J; Hertenstein B; Ganser A; Eder M
    Ann Hematol; 2008 Jul; 87(7):551-6. PubMed ID: 18386010
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Low-dose total body irradiation, fludarabine, and antithymocyte globulin conditioning for nonmyeloablative allogeneic transplantation.
    Grosskreutz C; Ross V; Scigliano E; Fruchtman S; Isola L
    Biol Blood Marrow Transplant; 2003 Jul; 9(7):453-9. PubMed ID: 12869959
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Favorable effect on acute and chronic graft-versus-host disease with cyclophosphamide and in vivo anti-CD52 monoclonal antibodies for marrow transplantation from HLA-identical sibling donors for acquired aplastic anemia.
    Gupta V; Ball SE; Yi QL; Sage D; McCann SR; Lawler M; Ortin M; Freires M; Hale G; Waldmann H; Gordon-Smith EC; Marsh JC
    Biol Blood Marrow Transplant; 2004 Dec; 10(12):867-76. PubMed ID: 15570255
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term outcome after bone marrow transplantation for aplastic anemia using cyclophosphamide and total lymphoid irradiation as conditioning regimen.
    Inamoto Y; Suzuki R; Kuwatsuka Y; Yasuda T; Takahashi T; Tsujimura A; Sugimoto K; Oba T; Terakura S; Atsuta Y; Murata M; Ito M; Kodera Y; Miyamura K
    Biol Blood Marrow Transplant; 2008 Jan; 14(1):43-9. PubMed ID: 18158960
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Unrelated stem cell transplantation for severe acquired aplastic anemia: improved outcome in the era of high-resolution HLA matching between donor and recipient.
    Maury S; Balère-Appert ML; Chir Z; Boiron JM; Galambrun C; Yakouben K; Bordigoni P; Marie-Cardine A; Milpied N; Kanold J; Maillard N; Socié G;
    Haematologica; 2007 May; 92(5):589-96. PubMed ID: 17488681
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Haploidentical Bone Marrow Transplantation with Post-Transplant Cyclophosphamide for Children and Adolescents with Fanconi Anemia.
    Bonfim C; Ribeiro L; Nichele S; Loth G; Bitencourt M; Koliski A; Kuwahara C; Fabro AL; Pereira NF; Pilonetto D; Thakar M; Kiem HP; Page K; Fuchs EJ; Eapen M; Pasquini R
    Biol Blood Marrow Transplant; 2017 Feb; 23(2):310-317. PubMed ID: 27832981
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Marrow transplantation from unrelated donors for patients with severe aplastic anemia who have failed immunosuppressive therapy.
    Deeg HJ; Seidel K; Casper J; Anasetti C; Davies S; Gajeweski JL; Territo M; Ramsay N; Harris RE; Catro-Malaspina H; Collins R; Champlin R; Schoch G; King R; Howe C
    Biol Blood Marrow Transplant; 1999; 5(4):243-52. PubMed ID: 10465104
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Improved Outcome of a Reduced Toxicity-Fludarabine, Cyclophosphamide, plus Antithymocyte Globulin Conditioning Regimen for Unrelated Donor Transplantation in Severe Aplastic Anemia: Comparison of 2 Multicenter Prospective Studies.
    Kang HJ; Hong KT; Lee JW; Kim H; Park KD; Shin HY; Lee SH; Yoo KH; Sung KW; Koo HH; Lee JW; Chung NG; Cho B; Kim HK; Koh KN; Im HJ; Seo JJ; Jung HJ; Park JE; Lee YH; Lim YT; Lim YJ; Kim SY; Yoo ES; Ryu KH; Lee JH; Park JA; Park SK; Ahn HS;
    Biol Blood Marrow Transplant; 2016 Aug; 22(8):1455-1459. PubMed ID: 27090956
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Non-total body irradiation containing preparative regimen in alternative donor bone marrow transplantation for severe aplastic anemia.
    Lee JH; Choi SJ; Lee JH; Lee YS; Seol M; Ryu SG; Lee JS; Kim WK; Lee KH
    Bone Marrow Transplant; 2005 Apr; 35(8):755-61. PubMed ID: 15735661
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Successful engraftment with fludarabine, cyclophosphamide, and thymoglobulin conditioning regimen in unrelated transplantation for severe aplastic anemia: A phase II prospective multicenter study.
    Kang HJ; Shin HY; Park JE; Chung NG; Cho B; Kim HK; Kim SY; Lee YH; Lim YT; Yoo KH; Sung KW; Koo HH; Im HJ; Seo JJ; Park SK; Ahn HS;
    Biol Blood Marrow Transplant; 2010 Nov; 16(11):1582-8. PubMed ID: 20685256
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Saudi experience in fludarabine-based conditioning regimens in patients with Fanconi anemia undergoing stem cell transplantation: excellent outcome in recipients of matched related stem cells but not in recipients of unrelated cord blood stem cells.
    Ayas M; Al-Seraihi A; El-Solh H; Al-Ahmari A; Khairy A; Aldali A; Markiz S; Siddiqui K; Al-Jefri A
    Biol Blood Marrow Transplant; 2012 Apr; 18(4):627-32. PubMed ID: 21871862
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cyclophosphamide combined with antithymocyte globulin in preparation for allogeneic marrow transplants in patients with aplastic anemia.
    Storb R; Etzioni R; Anasetti C; Appelbaum FR; Buckner CD; Bensinger W; Bryant E; Clift R; Deeg HJ; Doney K
    Blood; 1994 Aug; 84(3):941-9. PubMed ID: 8043876
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparable outcomes of matched-related and alternative donor stem cell transplantation for pediatric severe aplastic anemia.
    Kennedy-Nasser AA; Leung KS; Mahajan A; Weiss HL; Arce JA; Gottschalk S; Carrum G; Khan SP; Heslop HE; Brenner MK; Bollard CM; Krance RA
    Biol Blood Marrow Transplant; 2006 Dec; 12(12):1277-84. PubMed ID: 17162209
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Outcome of Unrelated Hematopoietic Stem Cell Transplants with Total Body Irradiation (800 cGy) and Cyclophosphamide (120 mg/kg) in Adult Patients with Acquired Severe Aplastic Anemia.
    Lee JW; Cho BS; Lee SE; Eom KS; Kim YJ; Kim HJ; Lee S; Min CK; Cho SG; Min WS; Park CW
    Biol Blood Marrow Transplant; 2011 Jan; 17(1):101-8. PubMed ID: 20601037
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.